Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

41.04
BATS BZX Real-Time Price
As of 2:35pm ET
 -0.21 / -0.51%
Today’s Change
39.27
Today|||52-Week Range
49.08
-3.98%
Year-to-Date

Today’s Trading

Previous close41.25
Today’s open41.10
Day’s range41.00 - 41.38
Volume1,174,259
Average volume (3 months)4,103,913
Market cap$100.4B
Dividend yield6.06%
Data as of 2:21pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)-46.46%
Earnings growth (this year)-20.80%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-8.75%
P/E ratio10.3
Price/Sales2.74
Price/Book15.09

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.93-1.53%
CELGCelgene-4.85-3.91%
ABBVAbbVie-1.40-2.19%
LLYEli Lilly and Co-0.82-0.99%
Data as of 2:35pm ET, 08/31/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)$0.63
Annual revenue (last year)$37.9B
Annual profit (last year)$4.5B
Net profit margin11.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers